Publication date: Jul 10, 2019
Dr Pippa Corrie presenting a talk at the 4th UK Melanoma Patient Conference in June 2019 about Side effects received from taking immunotherapy. Whether the impact and presence of these side effects means a long term durable response to treatment.
- A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
- KEYNOTE-029: pembrolizumab with ipilimumab for melanoma
- Adjuvant Treatment for Melanoma